Gaithersburg, MD, United States of America

Joann Suzich



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joann Suzich: Innovator in Respiratory Syncytial Virus Research

Introduction

Joann Suzich is a prominent inventor based in Gaithersburg, MD (US). She has made significant contributions to the field of virology, particularly in the development of vaccines for respiratory syncytial virus (RSV). Her innovative work has the potential to impact public health positively.

Latest Patents

Joann Suzich holds a patent for "Antibodies against and methods for producing vaccines for respiratory syncytial virus." This invention relates to novel RSV F peptides and compositions that include them. It also encompasses methods for evaluating anti-RSV antibody binding to these F peptides. Furthermore, her invention provides antibodies that specifically bind to an F peptide, along with methods for administering these peptides and antibodies for the prevention and treatment of RSV infection. The methods may also be beneficial for alleviating symptoms associated with RSV.

Career Highlights

Throughout her career, Joann has demonstrated a commitment to advancing medical science. Her work at MedImmune Limited has positioned her as a key player in the development of innovative solutions for viral infections. Her research has garnered attention for its potential to improve vaccine efficacy and patient outcomes.

Collaborations

Joann has collaborated with notable colleagues, including Josephine Mary McAuliffe and Frances Palmer-Hill. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments for RSV.

Conclusion

Joann Suzich's contributions to the field of virology, particularly through her patent on RSV vaccines, highlight her role as an influential inventor. Her work continues to pave the way for advancements in public health and vaccine development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…